HCA Healthcare Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
HCA Holdings (HCA) PT Raised to $378 at RBC Capital
July 24, 2024 6:23 AM EDTRBC Capital analyst Frank Morgan raised the price target on HCA Holdings (NYSE: HCA) to $378.00 (from $329.00) while maintaining a Outperform rating.
The analyst comments "HCA rose to the challenge of high 2Q24 expectations with an impressive beat and raise, driven by continued demand... More
HCA Holdings (HCA) Tops Q2 EPS by 60c
July 23, 2024 7:36 AM EDTHCA Holdings (NYSE: HCA) reported Q2 EPS of $5.53, $0.60 better than the analyst estimate of $4.93. Revenue for the quarter came in at $17.49 billion versus the consensus estimate of $17.05 billion.
GUIDANCE:
HCA Holdings sees FY2024 EPS of $21.60-$22.80, versus the consensus of... More
